Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
CardioComm Solutions, Inc. is a medical technology company focused on the development and commercialization of proprietary software solutions for cardiac monitoring and diagnostic data management. The company operates within the digital health, cardiac diagnostics, and medical software industries, providing tools that enable the collection, transmission, storage, and analysis of electrocardiogram (ECG) data. Its primary customers include hospitals, cardiac clinics, healthcare providers, and medical device companies seeking compliant and interoperable ECG data solutions.
The company’s core offerings are software platforms designed to support ECG device connectivity, remote cardiac monitoring workflows, and regulatory-compliant data management. CardioComm positions itself as a vendor-neutral software provider, enabling interoperability across multiple ECG devices and healthcare IT systems, which is cited as a strategic advantage in fragmented clinical environments. The company was founded in the late 1990s and has evolved from a traditional ECG data management provider into a developer of cloud-enabled and mobile-compatible cardiac software solutions as digital health adoption increased.
Business Operations
CardioComm Solutions generates revenue primarily through software licensing, recurring maintenance and support fees, and development services related to its cardiac data management platforms. Its operations are organized around software solutions for ECG data acquisition, remote transmission, analysis, and long-term storage, with applications in both clinical and research settings. The company does not manufacture hardware, instead integrating its software with third-party ECG devices and healthcare information systems.
Operations are conducted in Canada and the United States, serving customers in North America and select international markets through direct sales and distribution relationships. The company controls proprietary ECG software platforms and related intellectual property designed to meet healthcare regulatory and data security requirements. Public disclosures reference partnerships with medical device manufacturers and healthcare organizations, though specific long-term joint ventures or exclusive partnerships are not consistently detailed in available filings; data on the full scope of such relationships is inconclusive based on available public sources.
Strategic Position & Investments
CardioComm’s strategic direction emphasizes growth in remote patient monitoring, cloud-based cardiac data management, and software interoperability within digital health ecosystems. The company has highlighted efforts to expand recurring revenue streams through software-as-a-service–style offerings and long-term customer contracts, particularly as healthcare systems adopt remote and ambulatory cardiac monitoring solutions.
Public disclosures do not indicate large-scale acquisitions; instead, the company’s investment strategy appears focused on internal product development and incremental technology enhancements. Emerging areas of involvement include mobile health integration and secure cloud deployment of ECG data platforms. Information regarding material equity investments, portfolio companies, or major capital-intensive acquisitions is limited, and detailed confirmation of such activity is inconclusive based on available public sources.
Geographic Footprint
The company is headquartered in Canada and maintains operational and commercial activities in North America, with a particular emphasis on the United States healthcare market. Its software platforms are marketed to hospitals, clinics, and medical device partners primarily in these regions, where regulatory frameworks and reimbursement structures support digital cardiac monitoring.
Beyond North America, CardioComm has reported selective international deployments through partners and customers, though it does not disclose a broad physical presence across Europe, Asia-Pacific, or other regions. International influence is therefore characterized as commercial and software-based rather than through extensive overseas infrastructure, with limited publicly verified detail on the scale of non-North American operations.
Leadership & Governance
CardioComm Solutions was founded by Brent Armstrong, who continues to play a central role in shaping the company’s strategic vision, particularly its focus on interoperable and vendor-neutral cardiac software solutions. Leadership philosophy, as reflected in public communications, emphasizes regulatory compliance, clinical reliability, and long-term integration with evolving healthcare IT standards.
Key executives identified in public filings and disclosures include:
- Brent Armstrong – President and Chief Executive Officer
Public sources reference additional executive and senior management roles; however, names and titles beyond the Chief Executive Officer are not consistently disclosed across filings and investor materials. Data inconclusive based on available public sources.